focus -WSS

focus

author：fashion 2025-10-02 20:06:48 - browse：13293

Illustration oh researchers look up at a blister pill pac. Part of the blister pack is filled with pills, while the center shows a sketch of a brain. -- biotech coverage from STAT — Mike Reddy for STAT

One by one, the companies behind Zoloft, Prozac, and Paxil soured on psychiatry.

It was the early 2000s, and as America warmed to the sounds of Sisqó and Shakira, the world’s largest pharmaceutical firms were running out of ideas to treat mental illness. Their blockbuster treatments for depression and schizophrenia had reshaped society and made billions of dollars in the process, but the old cash cows were soon to go generic. Efforts to one-up the last generation of drugs mostly resulted in incremental changes to aging medicines. And when insurance companies balked at paying brand-name prices for extended-release generics, the money dried up and the industry moved out.

“The mindset of Big Pharma in those days was one pill for millions and millions of people,” said John LaMattina, who led Pfizer’s research division from 1999 to 2007. “Everyone was looking for the next Lipitor, and when that fizzled out, there was an exodus out of psychotherapeutic areas.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

WSS

It's time to take a new tack for treating Alzheimer's

A new deal aims to ramp up use of AI in rehab care decisions

Bring on the sabbaticals for nurses

Pfizer, Moderna say biotech, pharma drug development is a sprint

Readout LOUD podcast, live from the STAT Breakthrough Summit East

It's time to take a new tack for treating Alzheimer's

focus

focus

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

A new deal aims to ramp up use of AI in rehab care decisions

Novavax promises a turnaround & Lilly roils the obesity market

Hey, doctors: Don't be no

Bright Health sells Medicare Advantage business to Molina

Washington Commanders' Dan Snyder ordered to pay NFL $60M following investigation

In age of alternative facts, a scholarly course on calling out crap

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

Dobbs anniversary: the lost opportunity of abortion as health care

CRISPR technology availability, affordability needs to be expanded

leisure time

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

Washington Commanders' Dan Snyder ordered to pay NFL $60M following investigation

Erich Jarvis studies song birds to learn about human stuttering

Diabetes management: Digital health tools fall short, study says

Listen: BridgeBio's big week & Lilly's Alzheimer's data

leisure time

focus

leisure time

leisure time